Statistics for Early administration of imatinib mesylate reduces plexiform neurofibroma tumor burden with durable results after drug discontinuation in a mouse model of neurofibromatosis type 1

Total visits

views
Early administration of imatinib mesylate reduces plexiform neurofibroma tumor burden with durable results after drug discontinuation in a mouse model of neurofibromatosis type 1 107

Total visits per month

views
October 2024 0
November 2024 0
December 2024 0
January 2025 0
February 2025 0
March 2025 0
April 2025 0

File Visits

views
nihms-1628720.pdf 197
java.util.UUID:970c7e4f-65f6-4ab0-bf22-74091803c206 78
java.util.UUID:7a925d97-c1ba-4794-ad0a-90346410f0da 18
java.util.UUID:8e422b4a-792d-4b85-aaa9-6fa6e2215fd3 7

Top country views

views
United States 72
Belgium 10
Canada 2
Czechia 2
China 1
Germany 1
France 1
Italy 1
Mexico 1
Malaysia 1
Portugal 1
Sweden 1

Top city views

views
Wilmington 36
Fairfield 10
Houston 6
Moerbeke 5
Cambridge 3
Ann Arbor 2
Antwerpen 2
Molenbeek 2
San Francisco 2
Toronto 2
Beijing 1
Bloomfield 1
Chicago 1
Indianapolis 1
Kansas City 1
Kiez 1
Los Angeles 1
Mechelen 1
Mexico 1
Nanterre 1
Praha 1
Seattle 1
Segrate 1
Seremban 1
Slapanice 1
Stockholm 1